Capecitabine, DNA/RNA Synthesis Inhibitor
Por um escritor misterioso
Descrição
Capecitabine is an oral proagent that is converted to its active metabolite, 5-FU, by thymidine phosphorylase. - Mechanism of Action & Protocol.
5‑Fluorouracil and capecitabine therapies for the treatment of colorectal cancer (Review)
Potential specificity and synergy between radiation, capecitabine, and
Capecitabine, DNA, RNA and Protein Synthesis Inhibitors
Chemotherapy
TAS1553, a small molecule subunit interaction inhibitor of ribonucleotide reductase, exhibits antitumor activity by causing DNA replication stress
Regulation of thymidylate synthase: an approach to overcome 5-FU resistance in colorectal cancer
Biomedicines, Free Full-Text
Full article: DNA synthesis inhibitors for the treatment of gastrointestinal cancer
Targeting nucleotide metabolism: a promising approach to enhance cancer immunotherapy, Journal of Hematology & Oncology
Effects of microbiota on anticancer drugs: Current knowledge and potential applications - eBioMedicine
5‑Fluorouracil and capecitabine therapies for the treatment of colorectal cancer (Review)
de
por adulto (o preço varia de acordo com o tamanho do grupo)
